Developing a new antibiotic to fight drug-resistant infections
Synthesis and Evaluation of aza-Novo29 as an Antibiotic Candidate
This study is testing a new antibiotic called aza-Novo29 to see if it can effectively fight tough infections caused by drug-resistant bacteria like MRSA and VRE, which could offer new hope for patients struggling with these hard-to-treat conditions.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10624354 on NIH RePORTER |
What this research studies
This research focuses on creating and testing a new antibiotic candidate called aza-Novo29, specifically targeting drug-resistant Gram-positive bacteria like MRSA and VRE. The approach involves synthesizing aza-Novo29 to ensure it remains stable in the body, which is crucial for its effectiveness. By building on previous findings about similar antibiotics, the researchers aim to demonstrate that aza-Novo29 can effectively combat these resistant pathogens without breaking down too quickly. Patients may benefit from this research as it seeks to provide new treatment options for infections that are currently difficult to treat.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from infections caused by drug-resistant Gram-positive bacteria.
Not a fit: Patients with infections caused by non-Gram-positive bacteria or those not resistant to current antibiotics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new antibiotic that effectively treats infections caused by drug-resistant bacteria.
How similar studies have performed: Previous research has shown promise with similar antibiotic development approaches, indicating potential for success with aza-Novo29.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Nowick, James S — University of California-Irvine
- Study coordinator: Nowick, James S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.